• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱疼痛综合征/3C型间质性膀胱炎(ESSIC)患者的细胞因子表达

Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.

作者信息

Logadottir Yr, Delbro Dick, Fall Magnus, Gjertsson Inger, Jirholt Pernilla, Lindholm Catharina, Peeker Ralph

机构信息

Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

School of Health and Medical Sciences, Örebro University, Örebro, Sweden.

出版信息

J Urol. 2014 Nov;192(5):1564-8. doi: 10.1016/j.juro.2014.04.099. Epub 2014 May 9.

DOI:10.1016/j.juro.2014.04.099
PMID:24813342
Abstract

PURPOSE

Bladder wall nitric oxide production in patients with bladder pain syndrome type 3C is increased compared to undetectable nitric oxide in patients with nonHunner bladder pain syndrome and healthy controls. However, the underlying mechanism/s of the increased nitric oxide production is largely unknown. We compared mRNA expression of a select group of cytokines in patients with bladder pain syndrome/interstitial cystitis type 3C and in pain-free controls.

MATERIALS AND METHODS

Cold cup biopsies from 7 patients with bladder pain syndrome type 3C and 6 healthy subjects were analyzed. mRNA expression of IL-4, 6, 10 and 17A, iNOS, TNF-α, TGF-β and IFN-γ was estimated by real-time polymerase chain reaction. IL-17 protein expression was determined by immunohistochemistry. Mast cells were labeled with tryptase to evaluate cell appearance and count.

RESULTS

IL-6, 10 and 17A, and iNOS mRNA levels as well as the number of mast cells infiltrating the bladder mucosa were significantly increased in patients with bladder pain syndrome type 3C compared to healthy controls. TNF-α, TGF-β and IFN-γ mRNA levels were similar in patients and controls. IL-17A expression at the protein level was up-regulated and localized to inflammatory cells and urothelium in patients with bladder pain syndrome type 3C.

CONCLUSIONS

Patients with bladder pain syndrome/interstitial cystitis had increased mRNA levels of IL-17A, 10 and 6, and iNOS. IL-17A might be important in the inflammatory process. To our knowledge the increase in IL-17A is a novel finding that may have new treatment implications.

摘要

目的

与非Hunner膀胱疼痛综合征患者及健康对照者中无法检测到的一氧化氮相比,3C型膀胱疼痛综合征患者膀胱壁一氧化氮生成增加。然而,一氧化氮生成增加的潜在机制在很大程度上尚不清楚。我们比较了3C型膀胱疼痛综合征/间质性膀胱炎患者与无痛对照者中一组特定细胞因子的mRNA表达。

材料与方法

分析了7例3C型膀胱疼痛综合征患者和6名健康受试者的冷杯活检组织。通过实时聚合酶链反应估计白细胞介素-4、6、10和17A、诱导型一氧化氮合酶、肿瘤坏死因子-α、转化生长因子-β和干扰素-γ的mRNA表达。通过免疫组织化学测定白细胞介素-17蛋白表达。用类胰蛋白酶标记肥大细胞以评估细胞外观和计数。

结果

与健康对照者相比,3C型膀胱疼痛综合征患者中白细胞介素-6、10和17A以及诱导型一氧化氮合酶的mRNA水平以及浸润膀胱黏膜的肥大细胞数量显著增加。患者和对照者中肿瘤坏死因子-α、转化生长因子-β和干扰素-γ的mRNA水平相似。3C型膀胱疼痛综合征患者中白细胞介素-17A在蛋白水平的表达上调,并定位于炎症细胞和尿路上皮。

结论

膀胱疼痛综合征/间质性膀胱炎患者中白细胞介素-17A、10和6以及诱导型一氧化氮合酶的mRNA水平升高。白细胞介素-17A可能在炎症过程中起重要作用。据我们所知,白细胞介素-17A的增加是一项可能具有新治疗意义的新发现。

相似文献

1
Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.膀胱疼痛综合征/3C型间质性膀胱炎(ESSIC)患者的细胞因子表达
J Urol. 2014 Nov;192(5):1564-8. doi: 10.1016/j.juro.2014.04.099. Epub 2014 May 9.
2
Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.膀胱疼痛综合征ESSIC 3C型/经典间质性膀胱炎的炎症特征
Int J Urol. 2014 Apr;21 Suppl 1:75-8. doi: 10.1111/iju.12370.
3
Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.膀胱疼痛综合征/间质性膀胱炎ESSIC 3C型:炎症细胞中诱导型一氧化氮合酶的高表达
Scand J Urol. 2013 Feb;47(1):52-6. doi: 10.3109/00365599.2012.699100. Epub 2012 Jul 10.
4
Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.诱导型一氧化氮合酶在间质性膀胱炎患者活检组织中的定位与表达
J Urol. 2008 Aug;180(2):737-41. doi: 10.1016/j.juro.2008.03.184. Epub 2008 Jun 12.
5
Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?肥大细胞仍是膀胱疼痛综合征/间质性膀胱炎的良好生物标志物吗?
J Urol. 2015 Jun;193(6):1994-2000. doi: 10.1016/j.juro.2015.01.036. Epub 2015 Jan 14.
6
Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome.与间质性膀胱炎/膀胱疼痛综合征的膀胱容量相关的基因表达。
J Urol. 2014 Oct;192(4):1123-9. doi: 10.1016/j.juro.2014.05.047. Epub 2014 May 17.
7
CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis.在溃疡性间质性膀胱炎患者的膀胱尿路上皮中,CXCR3 结合趋化因子和 TNFSF14 过表达。
J Urol. 2010 Mar;183(3):1206-12. doi: 10.1016/j.juro.2009.11.007. Epub 2010 Jan 22.
8
Down-regulation of annexin A1 in the urothelium decreases cell survival after bacterial toxin exposure.尿路上皮中 annexin A1 的下调会减少细菌毒素暴露后细胞的存活率。
J Urol. 2013 Jul;190(1):325-33. doi: 10.1016/j.juro.2013.01.088. Epub 2013 Jan 31.
9
Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.膀胱疼痛综合征/3C型间质性膀胱炎的局部免疫反应
Int Urogynecol J. 2013 Dec;24(12):2049-57. doi: 10.1007/s00192-013-2112-0. Epub 2013 May 14.
10
Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.膀胱疼痛综合征/间质性膀胱炎患者潜在的尿液和血清生物标志物。
Int J Urol. 2014 Apr;21 Suppl 1:34-41. doi: 10.1111/iju.12311.

引用本文的文献

1
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS.间质性膀胱炎/膀胱疼痛综合征的病理生理学及潜在多模式治疗策略
Nat Rev Urol. 2025 May 15. doi: 10.1038/s41585-025-01044-4.
2
Effect of pro-inflammatory cytokines on urothelial cell adenosine triphosphate release and breakdown.促炎细胞因子对尿路上皮细胞三磷酸腺苷释放和分解的影响。
Bladder (San Franc). 2024 Sep 12;11(2):e21200006. doi: 10.14440/bladder.2024.0011. eCollection 2024.
3
The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome.
慢性间质性膀胱炎和膀胱疼痛综合征的发病机制及当前治疗方法
Biomedicines. 2024 Sep 10;12(9):2051. doi: 10.3390/biomedicines12092051.
4
A Dynamic Interplay of Innate Immune Responses During Urinary Tract Infection.尿路感染期间固有免疫反应的动态相互作用
Immune Netw. 2024 Jul 22;24(4):e31. doi: 10.4110/in.2024.24.e31. eCollection 2024 Aug.
5
Divergent histopathological and molecular patterns in chemically induced interstitial cystitis/bladder pain syndrome rat models.化学诱导的间质性膀胱炎/膀胱疼痛综合征大鼠模型中的组织病理学和分子模式的差异。
Sci Rep. 2024 Jul 12;14(1):16134. doi: 10.1038/s41598-024-67162-y.
6
Cytokines in Bladder Pain Syndrome: A Review of the Literature.膀胱疼痛综合征中的细胞因子:文献综述。
Int Urogynecol J. 2024 Jun;35(6):1119-1129. doi: 10.1007/s00192-024-05778-4. Epub 2024 May 21.
7
Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis.1型辅助性T细胞/17型辅助性T细胞极化及抗干扰素-γ DNA适配体对间质性膀胱炎的潜在治疗作用
iScience. 2023 Oct 21;26(11):108262. doi: 10.1016/j.isci.2023.108262. eCollection 2023 Nov 17.
8
TGF-β inhibitor treatment of H₂O₂-induced cystitis models provides biochemical mechanism for elucidating interstitial cystitis/painful bladder syndrome patients.TGF-β 抑制剂治疗 H₂O₂ 诱导的膀胱炎模型为阐明间质性膀胱炎/膀胱疼痛综合征患者提供了生化机制。
PLoS One. 2023 Nov 6;18(11):e0293983. doi: 10.1371/journal.pone.0293983. eCollection 2023.
9
Interleukin-17 as a potential therapeutic target for chronic pain.白细胞介素-17 作为慢性疼痛的潜在治疗靶点。
Front Immunol. 2022 Sep 29;13:999407. doi: 10.3389/fimmu.2022.999407. eCollection 2022.
10
Gene Expression-Based Functional Differences between the Bladder Body and Trigonal Urothelium in Adolescent Female Patients with Micturition Dysfunction.青少年女性排尿功能障碍患者膀胱体部与膀胱三角区尿路上皮基于基因表达的功能差异
Biomedicines. 2022 Jun 17;10(6):1435. doi: 10.3390/biomedicines10061435.